# Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding

> **NCT06106971** · PHASE3 · UNKNOWN · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 68 (estimated)

## Conditions studied

- Gastric Varices Bleeding
- Liver Decompensation

## Interventions

- **DRUG:** Sodium tetradecyl sulfate
- **DRUG:** Cyanoacrylate

## Key facts

- **NCT ID:** NCT06106971
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-28
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06106971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06106971, "Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT06106971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*